Stories of achievement and discovery from across our research community.
Check out previous posts in our archive to see more research highlights and department achievements.
Jun 1, 2026
Sharon Cantor Receives NIH Grant to Investigate New Role for BRCA1
Sharon Cantor, PhD, has received an R01 grant from the National Cancer Institute to explore the role of BRCA1 in coordinating lagging strand DNA synthesis, with implications for developing new treatments for hereditary breast and ovarian cancers, including tumors resistant to PARP inhibitors.
Read more
Breast Cancer,Cancer,Faculty Grants,Ovarian Cancer, MCCB
May 29, 2026
Richard Gregory Receives Pershing Square Lotus Award
Richard Gregory, PhD, is one of eight scientists in the country to receive a 2026 Lotus Award from the Pershing Square Foundation to advance innovative ovarian cancer research.
Cantor Lab Uncovers New Vulnerability in BRCA1-deficient Cancers
Sharon Cantor has identified a targetable vulnerability in BRCA1-deficient cells—a finding with potential implications for the treatment of inherited breast and ovarian cancers.
Read more
Breast Cancer,Cancer,Ovarian Cancer,Publications, MCCB
May 12, 2025
MCCB Student Receives NIH Fellowship to Study Chemoresistance in BRCA-Mutant Cancers
Nate MacGilvary is investigating how chemoresistance develops in BRCA-mutant breast and ovarian tumors to identify targetable mechanisms that could improve patient outcomes.
Read more
Breast Cancer,Cancer,Ovarian Cancer,Student Fellowships, MCCB